PAX6 and eye disorder: To determine how the absence of SPP affects eye disease/corneal scarring and angiogenesis, infected Pax6-SPP-/- and WT control mice described in Fig 5 above were scored for eye disease/corneal scarring and angiogenesis on days 2, 4, 8, 14, 21, and 28 PI as described in the Materials and Methods.